Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview. (January 2016)
- Record Type:
- Journal Article
- Title:
- Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview. (January 2016)
- Main Title:
- Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers
- Authors:
- Azad, Gurdip Kaur
Taylor, Benjamin
Rubello, Domenico
Colletti, Patrick M.
Goh, Vicky
Cook, Gary J. - Abstract:
- Abstract : Abstract: Our ability to accurately assess the skeleton for metastases in breast and prostate cancers has improved significantly in recent years with hybrid imaging methods. Nevertheless, no consensus has been reached on the best imaging modality for diagnosis and treatment response assessment of skeletal disease. Hybrid SPECT/CT has low false-positive and false-negative rates compared with planar bone scintigraphy (BS) or BS augmented with SPECT in breast and prostate cancers. In breast cancer, 18 F-FDG PET is more sensitive and accurate at detecting bone metastases than BS. Currently, little evidence has accrued to support the superiority of 18 F-fluoride ( 18 F-NaF) PET in diagnosing osseous metastases or monitoring treatment response in breast cancer when compared with conventional imaging. In prostate cancer, the sensitivities of 18 F-NaF PET/CT, 18 F-fluorocholine ( 18 F-choline), or 11 C-choline PET/CT are equivalent, although 11 C-/ 18 F-choline PET/CT scans are more specific. Whole-body MRI, using anatomical sequences complemented by diffusion-weighted MRI, shows early evidence of utility for diagnosis and monitoring therapy response. We review the literature for staging and response assessment in metastatic breast and prostate cancer. While staging accuracy has significantly improved with hybrid imaging, optimal methods for assessing early treatment response have not been determined, and this is an area of active research.
- Is Part Of:
- Clinical nuclear medicine. Volume 41:Number 1(2016)
- Journal:
- Clinical nuclear medicine
- Issue:
- Volume 41:Number 1(2016)
- Issue Display:
- Volume 41, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 41
- Issue:
- 1
- Issue Sort Value:
- 2016-0041-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-01
- Subjects:
- PET -- FDG -- choline -- fluoride -- diffusion-weighted MRI -- breast cancer -- prostate cancer
Nuclear medicine -- Periodicals
Radioisotope scanning -- Periodicals
Nuclear Medicine -- Periodicals
616.07575 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00003072-000000000-00000 ↗
http://journals.lww.com/nuclearmed/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/RLU.0000000000000993 ↗
- Languages:
- English
- ISSNs:
- 0363-9762
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4958.xml